2020
DOI: 10.1016/j.bbcan.2020.188354
|View full text |Cite
|
Sign up to set email alerts
|

Role of fibrillin-2 in the control of TGF-β activation in tumor angiogenesis and connective tissue disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
22
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 157 publications
2
22
1
Order By: Relevance
“…In addition, SFRP2-directed ultrasound imaging clearly shows specific signal in the tumor vasculature, while normal vessels are not visualized [6]. Proteins such as SFRP2, that seem to be specifically (over)expressed in the tumor vasculature, show great promise as therapeutic targets in the fight against cancer [7][8][9]. To enhance insight in oncogenic role of SFRP2, we performed a literature study about SFRP2 in Wnt signaling and tumor angiogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, SFRP2-directed ultrasound imaging clearly shows specific signal in the tumor vasculature, while normal vessels are not visualized [6]. Proteins such as SFRP2, that seem to be specifically (over)expressed in the tumor vasculature, show great promise as therapeutic targets in the fight against cancer [7][8][9]. To enhance insight in oncogenic role of SFRP2, we performed a literature study about SFRP2 in Wnt signaling and tumor angiogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have shown that methylation or silencing of FBN2 in tumor cells may play an important role in carcinogenesis, invasion, and metastasis (67). However, recent research suggested the opposite, wherein FBN2 stimulates tumor angiogenesis by influencing TGF-β sequestration by microfibrils, leading to a locally higher active TGF-β concentration in the tumor microenvironment which is involved in tumor progression, metastasis, EMT, and tumor angiogenesis (68). In lung cancer, cholangiocarcinoma, and metastatic colorectal cancer, FBN2 has been found to be associated with EMT, cell migration, and metastasis (69)(70)(71).…”
Section: Discussionmentioning
confidence: 99%
“…It is well known that mutation of FBN2 leads to dominant heritable connective tissue disorders [64]. Importantly, a recent review article has gained insight on fibrillin-2 as a critical mediator that binds to transforming growth factor-beta (TGF-β) during extracellular matrix formation [65]. The TLR9/ TGF-β1/PDGF-β pathway was excessively activated in peripheral mononuclear cells isolated from LN patients [66].…”
Section: Discussionmentioning
confidence: 99%